Pneumococcal and H. influenzae



Similar documents
Chapter 3. Immunity and how vaccines work

Basics of Immunology

Chapter 18: Applications of Immunology

Childhood ENT disorders. When to refer to specialists. Claire Harris

Transient Hypogammaglobulinemia of Infancy. Chapter 7

MENZIES SCHOOL OF HEALTH RESEARCH FINAL REPORT

Immunity and how vaccines work

Summary and Conclusions

Pertussis Information for GPs and other Health Care Providers on Clinical and Public Health Management. March 2010

Queensland Health Information Asset Register as at 30 September 2015

Solid Organ Transplantation

Immunity Unit Test Z

Principles of Vaccination

How Does a Doctor Test for AIDS?

Basic Immunologic Procedures. Complex Serological Tests

Core Topic 2. The immune system and how vaccines work

PENNSYLVANIA DEPARTMENT OF HEALTH 2015 PAHAN ADV Pertussis in Centre County

Antigens & Antibodies II. Polyclonal antibodies vs Monoclonal antibodies

CONTENT. Chapter 1 Review of Literature. List of figures. List of tables

Multiple Choice Questions

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

Why use passive immunity?

Selective IgA deficiency (slgad)

Blood-Based Cancer Diagnostics

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors.

Animal Health Diagnostic Center. Lyme Disease Multiplex Testing for Dogs. Background on Lyme disease and Lyme diagnostics in dogs

Principles of Vaccination

JIANGSU CARTMAY INDUSTRIAL CO.,LTD mail:

Appendix 3 Exposure Incident Report Form

Cytomegalovirus (HHV5/CMV) Roseolovirus (HHV6 & 7)

2 months Diptheria; Tetanus; Whooping Cough; Hib & Polio 1st dose Pneumococcal Conjugate Vaccination

Topic: Serological reactions: the purpose and a principle of reactions. Agglutination test. Precipitation test. CFT, IFT, ELISA, RIA.

Haemophilus influenzae type b

The timing of vaccination with respect to anaesthesia and surgery. 1. Surgery following immunisation with inactivated vaccines

3.0 Treatment of Infection

Diagnostic Testing and Strategies for BVDV

Immunology Ambassador Guide (updated 2014)

HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13

Vaccinations and Spina Bifida and Hydrocephalus

Some Immunological Test. Presented by Alaa Faeiz Ashwaaq Dyaa Aseel Abd AL-Razaq Supervised by D.Feras

PERTUSSIS SURVEILLANCE AND RESPONSE PROTOCOL

CHAPTER 2 ANTIGEN/ANTIBODY INTERACTIONS

Introduction to Microbiology The Microbial World and You (Chapter 1) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College

Influenza (Flu) Influenza is a viral infection that may affect both the upper and lower respiratory tracts. There are three types of flu virus:

Prospects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS

Functions of Blood. Collects O 2 from lungs, nutrients from digestive tract, and waste products from tissues Helps maintain homeostasis

Haemophilus influenzaetype b (Hib) Vaccination Position Paper. July 2013

MEDICAL MICROBIOLOGY 603 OR POPULATION HEALTH SCIENCES 603 CLINICAL AND PUBLIC HEALTH MICROBIOLOGY January 18-May 6, 2011

The Case of Baby Joe by Kristen L.W. Walton Page 1

Viral Hepatitis Case Report

Pentavalent Vaccine. Guide for Health Workers. with Answers to Frequently Asked Questions

Chapter 43: The Immune System

The Immune System. 2 Types of Defense Mechanisms. Lines of Defense. Line of Defense. Lines of Defense

HSA Consumer Guide. Understanding Vaccines, Vaccine Development and Production. November How a Vaccine Works.

Candy Antigens and Antibodies

Management of Acute Otitis Media: Update

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart

Severe Combined Immune Deficiency (SCID)

HLA-Cw*0602 associates with a twofold higher prevalence. of positive streptococcal throat swab at the onset of

Focus on Preventing Disease. keeping an eye on a healthy bottom line. Cattle Industry

Notes. Complete childhood vaccination course (CCV) CCV and DTP booster as adolescent/adult within last 10 years

A Practical Guide to Diagnosis and Treatment of Infection in the Outpatient Setting Diagnosis and Treatment of Urinary Tract Infections

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics

OpenMedicine Foundation (OMF)

Laboratory confirmation requires isolation of Bordetella pertussis or detection of B. pertussis nucleic acid, preferably from a nasopharyngeal swab.

VETERINARY SERVICES MEMORANDUM NO

Management of Specific clinical situations (dialysis, hemoglobinopathy, splenectomy)

The Immune System and Disease

GP Masterclass ENT Hillingdon. Mr Arvind Singh Consultant ENT Surgeon Hillingdon, Mount Vernon, Northwick Park and Central Middlesex Hospitals

About Our Products. Blood Products. Purified Infectious/Inactivated Agents. Native & Recombinant Viral Proteins. DNA Controls and Primers for PCR

Pneumonia Education and Discharge Instructions

Effector Mechanisms of Humoral Immunity

OTITIS MEDIA PREVENTION CAMPAIGN

Borrelia burgdorferi IgG, IgM Fully automated chemiluminescence assays for quantitative determination of Borrelia antibodies in serum and CSF

Microbiology AN INTRODUCTION EIGHTH EDITION

ELISA BIO 110 Lab 1. Immunity and Disease

The Body s Defenses CHAPTER 24

Current Status of GBS vaccine Research and Development

Guidance Document Infectious Substances

PRIORITY RESEARCH TOPICS

Changing Concept of FMD diagnostics: from Central to Local. Aniket Sanyal Project Directorate on FMD Mukteswar, India

10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells.

Immune-Mediated Low Platelet or Thrombocyte Count

TRACKS INFECTIOUS DISEASE EPIDEMIOLOGY

Diseases of the middle ear

Transcription:

Pneumococcal and H. influenzae protein specific IgG and IgA are present in serum and the middle ear effusion of children with a history of recurrent acute otitis media Karli Corscadden

The GROMIT study Investigating the immunology, genetics and microbiology of recurrent acute otitis media in children Otitis media cases 201 children < 36 months At least 3 episodes of AOM Admitted to hospital for grommet insertion Healthy controls 89 children < 36 months No history of ear disease Admitted to hospital for minor surgical procedures Genesis of R ecurrent Otitis Media in I nfants and T oddlers Blood and saliva samples for immune analysis and nasopharyngeal swabs for culture OM children, middle ear effusion (MEE) for bacterial culture and PCR and to investigate the local immune response in the middle ear Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) were the most common pathogens isolated from nasopharynx carriage rates in raom children were significantly higher compared to healthy children NTHi was the predominate pathogen detected in MEE using PCR (culture rates for both S. pneumoniae and NTHI were low)

Investigating the immune system of children with a history of raom Current vaccines have had limited impact reducing raom New vaccines containing conserved protein antigens for these bacteria could confer species wide protection Little is known about the immunogenicity of these protein in raom children To determine whether children with raom mount an antibody response to potential vaccine candidate protein antigens from S. pneumoniae and NTHi Developed a novel bead-based multiplex assay (which requires minimal amount of serum) to measure IgG antibodies to; 4 pneumococcal specific protein antigens: pneumococcal surface protein A families 1 (PspA1) and 2 (PspA2), choline binding protein (CbpA) and pneumolysin (Ply) 3 nontypeable H. influenzae outer membrane proteins P4, P6 and PD Antibody levels for all protein antigens were compared between children with a history of raom and healthy children Levels correlated with the age of the children and carriage data

Protein specific IgG in serum S. pneumoniae and NTHi protein specific IgG was detected in the serum of children with a history of raom and healthy children Antibodies are produced to these protein antigens Children colonised with S. pneumoniae or NTHI had higher protein specific IgG antibodies in their serum to the respective bacteria Antibodies are produced during colonisation and these protein antigens are immunogenic in children with raom Protein specific IgG increased with the age of the child for both groups of children Increased exposure and immune development of the child

Conclusion: Protein antigens from S. pneumoniae and NTHi induce serum IgG in children with a history of raom and these levels are comparable to children with no history of raom Vaccines containing these conserved bacterial proteins antigens could help to reduce the incidents of AOM and decrease the burden of raom Acute otitis media is a mucosal disease, so what is going on at the site of infection (in the middle ear itself) Little is known about the immune response within the middle ear of children with raom The presence of antibodies in the middle ear may be more important in clearing bacterial infection and preventing recurrent acute otitis media

Investigate if pneumococcal and NTHi protein specific IgG and IgA are present in the MEE samples from children with recurrent AOM MEE samples were collected into saline from children undergoing grommet insertion Total IgG and IgA in the MEE samples was determined by nephelometry Used samples with detectable total IgG (n=139) and IgA(n=115) Measured S. pneumoniae and NTHi protein specific IgG and IgA in the MEE PspA1, PspA2, CbpA (IgG only), PLY, P4, P6 and Protein D Protein specific antibodies were reported as a ratio (arbitrary units) of protein specific antibodies within total antibodies to control for variability in sample dilution Results were compiled and MEE arbitrary units were correlated with carriage data, age of subject and serum IgG (measuring protein IgA is ongoing)

Pneumococcal and NTHi protein specific IgG is present in the middle ear effusion of children with a history raom

There is a positive correlation between protein specific IgG in serum and MEE for all protein antigens p= 0.002 p= 0.004 p= <0.001 p= <0.001 Suggests that antibodies in the serum transudate to the middle ear Vaccination with protein vaccines could result in antibodies in the middle ear and the presence of these antibodies could prevent against raom

Pneumococcal and NTHi protein specific IgA is present in the middle ear effusion of children with a history raom

Pneumococcal protein IgG and IgA in MEE tends to increases with age PspA1 PspA2 IgG IgA PLY Increased exposure to pneumococcus over time and also immune development Different ratios of IgG and IgA within proteins PspA1 Greater IgA PspA2 Greater IgG PLY Greater IgG but both are present

NTHi protein specific IgG and IgA tended to increase with age P4 P6 IgG IgA PD Increased exposure to NTHi over time and also immune development Different ratios of IgG and IgA within proteins P4 Greater ratio of IgA P6 Greater ratio of IgG PD Equal levels of IgG and IgA

Children colonised in the nasopharynx by the respective bacteria have higher IgG and IgA antibodies to bacteria specific proteins IgG IgA Not colonised Colonised Trend the same as seen for serum IgG raom children produce antibodies in response to colonisation these proteins are immunogenic in raom children

Children with NTHi detected in there MEE sample have higher IgG and IgA antibodies to NTHi specific proteins IgG IgA NTHi present NTHi not present Trend the same as seen for serum IgG and MEE IgG children colonised at the time of sample collection have higher IgG and IgA antibodies to bacteria proteins raom children produce antibodies to these bacteria during colonisation These proteins are immunogenic in raom children

Conclusions Children with a history of raom are able to produce IgG antibodies against pneumococcal and NTHi proteins in serum at least as well as healthy children In raom children, IgG and IgA antibodies are present in the middle ear and IgG correlates well with serum IgG Suggests antibodies in the serum, which could be induced by vaccination, can enter the middle ear space and could potentially help in clearing these bacteria at the site of infection Protein specific IgG and IgA levels increase in the middle ear with age may be due to increase exposure to these bacteria over time raom children colonised during sample collection tended to have higher protein antibodies in the middle ear Suggesting raom do produce antibodies to these proteins Pneumococcal and NTHi protein antigens are immunogenic in raom children and vaccines including these proteins may provide species wide protection and may help to reduce the incidence and burden of raom

Future work Measure protein specific IgA in the serum sample collected from raom and healthy children correlate IgA in the serum with IgA in the middle ear Measure protein specific IgG and IgA in the saliva samples collected from raom and healthy children Investigate the local mucosal response in raom children Investigate the functionality of these protein antibodies in the serum and saliva samples (Ply functionality in serum already done) If antibodies are present are they functioning correctly and able to protect against infection with these bacteria Evaluate these protein antibodies responses in Aboriginal children

Acknowledgements VTG/UWA Peter Richmond Selma Wiertsema Lea-Ann Kirkham Ruth Thornton Eva Mowe Janessa Pickering Amy Prosser Andrew Currie Samantha Curtis Fiona McDonald Alison Roberts ENT Harvey Coates Shyan Vijayasekaran Tim Cooney PathWest Tom Riley Jacinta Bowman Jade Jones Gerry Harnett Glenys Chidlow Hospitals & Staff Princess Margaret Hospital for Children Colin Street Day Surgery McCourt Street Day Surgery St John of God Subiaco and Murdoch Funding UWA Project Grant GlaxoSmithKline Australia European Society for Paediatric Infectious Diseases Princess Margaret Hospital Foundation National Health and Medical Research Council Telethon Institute for Child Health Research All the children and parents who participated in the GROMIT Study Genesis of R ecurrent Otitis Media in I nfants and T oddlers

Demographics (don t think need to include) raom Healthy p-value Number 169 77 n/a Mean age (months) 21.1 16.9 0.01 Male (%) 61.5% 75.3% 0.034 AOM episodes total (n=157) 0 2-77 (100%) 3 4 50 (31.8%) - 5 7 27 (17.2%) - 8 9 57 (36.4%) - 10 23 (14.6%) - Median # AOM episodes 7 n/a Day care attendance (>4hrs) 67.7% 29.3% <0.001 Currently on antibiotics 24.4% 16.0% 0.15 Have siblings 70.3% 67.6% 0.68